author-photo

Noemi Reguart

University of California, San Francisco

228

Papers

11008

Citations

Citation Trend

Filter By

Papers (228) Sort By

Journal Conference Others

Abstract 951: Evolution of antibody titers, growth factor levels and in vitro activity in the sera of patients enrolled in the EPICAL trial of afatinib combined with anti-EGF vaccination

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
MA03.01 EPICAL Trial. A Phase Ib StudyCombining Anti-Epidermal Growth Factor (EGF) Vaccination With Afatinib in EGFR-Mutant Non-Small Cell Lung Cancer

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Updated results from a phase 1 study of AMG 757, a half-life extended bispecific T-cell engager (BiTE) immuno-oncology therapy against delta-like ligand 3 (DLL3), in small cell lung cancer (SCLC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
OA02.03 Pembrolizumab Plus Platinum Chemotherapy and Radiotherapy in Unresectable, Locally Advanced, Stage III NSCLC: KEYNOTE-799

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Patients with Non-small Cell Lung Cancer of Squamous Histology: Focus on Afatinib

2021 Oral History Review
- Noemi Reguart
- Roxana Reyes
Show All
- Source
- Cite
- Save
Citations (0)
KEYLYNK-012: A Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy (CCRT) Followed by Pembrolizumab With or Without Olaparib vs. CCRT Followed by Durvalumab in Unresectable, Locally Advanced, Stage III Non‒Small-Cell Lung Cancer.

2021 International Journal of Radiation Oncology Biology Physics
Show All
- Source
- Cite
- Save
Citations (0)
Author response for "NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment"

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3167: Stromal TIMP-1 drives tumor progression in lung adenocarcinoma through CD63 interaction

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions

2021
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.

2021 JAMA Oncology
Show All
- Source
- Cite
- Save
Citations (6)